HC Wainwright & Co. analyst Scott Buck maintains Draganfly (NASDAQ:DPRO) with a Buy and raises the price target from $2 to $3.5.
Here’s How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 44.59% on an annualized basis…